Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis
Author(s) -
Dafna Ben Yaakov,
Anna Rivkin,
Gabriel Mircus,
Nathaniel D. Albert,
Anna-Maria Dietl,
Dimitry Kovalerchick,
Shmuel Carmeli,
Hubertus Haas,
Dimitrios P. Kontoyiannis,
Nir Osherov
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv446
Subject(s) - aspergillus fumigatus , biology , microbiology and biotechnology , aspergillus nidulans , galleria mellonella , in vivo , biochemistry , virulence , mutant , gene
During recent decades, the number of invasive fungal infections among immunosuppressed patients has increased significantly, whereas the number of effective systemic antifungal drugs remains low and unsatisfactory. The aim of this study was to characterize a novel antifungal compound, CW-8/haemofungin, which we previously identified in a screen for compounds affecting fungal cell wall integrity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom